SubsidieMeestersBringing newborn care home: An integral mHealth solution for neonatal jaundice management.
Picterus is creating a digital platform for at-home neonatal jaundice screening, empowering families to monitor conditions and streamline healthcare referrals, improving outcomes and resource efficiency.
Projectdetails
Introduction
Neonatal jaundice (NNJ) affects 60%-80% of newborns worldwide (84-112 million/year). Ten percent will develop severe jaundice (SNJ), which can cause permanent brain damage or even death. Each year, approximately 114,000 newborns die due to this condition, and 75,000 suffer severe long-term neurological impairments.
Current Challenges
A fast, point-of-care, affordable method for NNJ screening and monitoring in the first 2 weeks of life is crucial. However, current methods are insufficient, including:
- Visual assessment
- Transcutaneous device
- Blood test
Resource Pressures
Health systems face increasing pressure on their resources. It is imperative to develop more sustainable models of care and empower patients and their families.
Project Overview
Picterus is developing the first digital platform to enable NNJ screening by parents and caregivers at home. This platform will facilitate timely referrals to healthcare services.
Features of the Platform
Our recommendation tool will allow families to:
- Monitor NNJ at home with their smartphones.
- Enable healthcare workers to efficiently manage a greater number of families by avoiding unnecessary visits.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.999 |
| Totale projectbegroting | € 3.938.916 |
Tijdlijn
| Startdatum | 1-9-2023 |
| Einddatum | 31-8-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- PICTERUS ASpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
The first medical device for non-invasive detection and monitoring of infant meningitisNEOSONICS is a non-invasive ultrasound device that detects infant meningitis by analyzing cerebrospinal fluid white blood cell levels, aiming to reduce reliance on risky lumbar punctures. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Advanced Remote Continuous patient Health mANaGemEnt SoLutionCheckpointcardio aims to revolutionize patient monitoring by establishing a 24/7 remote observation center using AI and wearables to enhance care for critically ill and chronic disease patients. | EIC Accelerator | € 2.436.000 | 2023 | Details |
A first-in-class therapy for intestinal malabsorption in premature newbornsELGN-GI is a pioneering drug aimed at accelerating gut maturation in preterm infants, reducing reliance on parenteral nutrition and lowering risks of infections and complications. | EIC Accelerator | € 2.359.000 | 2022 | Details |
Sonio: Deep-Learning for Detection and Diagnostic of Prenatal MalformationsSonio is an AI-driven platform that enhances fetal ultrasound by guiding OBGYNs in detecting congenital malformations, aiming to improve prenatal diagnosis accuracy and outcomes. | EIC Accelerator | € 2.500.000 | 2023 | Details |
Point of care diagnostic solution for definitive differentiation of true and false threatened preterm labour casesINNITIUS aims to optimize TPTL diagnosis with Fine Birth, a non-invasive AI-driven device that assesses cervical tissue consistency, seeking €2.5M for further development and regulatory approval. | EIC Accelerator | € 2.342.835 | 2023 | Details |
The first medical device for non-invasive detection and monitoring of infant meningitis
NEOSONICS is a non-invasive ultrasound device that detects infant meningitis by analyzing cerebrospinal fluid white blood cell levels, aiming to reduce reliance on risky lumbar punctures.
Advanced Remote Continuous patient Health mANaGemEnt SoLution
Checkpointcardio aims to revolutionize patient monitoring by establishing a 24/7 remote observation center using AI and wearables to enhance care for critically ill and chronic disease patients.
A first-in-class therapy for intestinal malabsorption in premature newborns
ELGN-GI is a pioneering drug aimed at accelerating gut maturation in preterm infants, reducing reliance on parenteral nutrition and lowering risks of infections and complications.
Sonio: Deep-Learning for Detection and Diagnostic of Prenatal Malformations
Sonio is an AI-driven platform that enhances fetal ultrasound by guiding OBGYNs in detecting congenital malformations, aiming to improve prenatal diagnosis accuracy and outcomes.
Point of care diagnostic solution for definitive differentiation of true and false threatened preterm labour cases
INNITIUS aims to optimize TPTL diagnosis with Fine Birth, a non-invasive AI-driven device that assesses cervical tissue consistency, seeking €2.5M for further development and regulatory approval.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Thuisbehandeling en monitoring van geelzucht bij pas- en vroeggeborenen: User flowHet project richt zich op het ontwikkelen van effectieve behandelingen voor geelzucht bij pasgeborenen, met speciale aandacht voor vroeggeborenen om neurologische schade te voorkomen. | Mkb-innovati... | € 20.000 | 2022 | Details |
Early Moves at Home: a deployable and scalable serviceHet project richt zich op het vroegtijdig diagnosticeren van ontwikkelingsstoornissen bij hoog-risico pasgeborenen thuis, om de ontwikkeling van kinderen te verbeteren en zorgkosten te verlagen. | Mkb-innovati... | € 200.000 | 2022 | Details |
Preterm Brain-Oxygenation and Metabolic EU-Sensing: Feed the BrainPrometeus aims to personalize nutrition for premature neonates in NICUs through real-time adjustments of glucose and nutrients based on brain needs, reducing the risk of neurodevelopmental disabilities. | EIC Pathfinder | € 3.554.156 | 2023 | Details |
Innovatief patiënt monitoringsysteem voor sepsis in baby’s en jonge kinderen in lage- en middeninkomenslanden.GOAL 3 ontwikkelt een betaalbaar patiëntmonitoringsysteem voor vroegtijdige detectie van septische shock bij baby’s in LMIL, gericht op het verbeteren van zorgcapaciteiten en -resultaten. | Mkb-innovati... | € 20.000 | 2020 | Details |
Premature baby's draadloos monitoren met de Bambi BeltHet project ontwikkelt de Bambi Belt, een draadloos en huidvriendelijk monitoringsysteem voor premature baby’s, om stress en pijn te verminderen en de kwaliteit van zorg te verbeteren, wat ziekenhuisverblijven verkort en kosten verlaagt. | Mkb-innovati... | € 348.460 | 2017 | Details |
Thuisbehandeling en monitoring van geelzucht bij pas- en vroeggeborenen: User flow
Het project richt zich op het ontwikkelen van effectieve behandelingen voor geelzucht bij pasgeborenen, met speciale aandacht voor vroeggeborenen om neurologische schade te voorkomen.
Early Moves at Home: a deployable and scalable service
Het project richt zich op het vroegtijdig diagnosticeren van ontwikkelingsstoornissen bij hoog-risico pasgeborenen thuis, om de ontwikkeling van kinderen te verbeteren en zorgkosten te verlagen.
Preterm Brain-Oxygenation and Metabolic EU-Sensing: Feed the Brain
Prometeus aims to personalize nutrition for premature neonates in NICUs through real-time adjustments of glucose and nutrients based on brain needs, reducing the risk of neurodevelopmental disabilities.
Innovatief patiënt monitoringsysteem voor sepsis in baby’s en jonge kinderen in lage- en middeninkomenslanden.
GOAL 3 ontwikkelt een betaalbaar patiëntmonitoringsysteem voor vroegtijdige detectie van septische shock bij baby’s in LMIL, gericht op het verbeteren van zorgcapaciteiten en -resultaten.
Premature baby's draadloos monitoren met de Bambi Belt
Het project ontwikkelt de Bambi Belt, een draadloos en huidvriendelijk monitoringsysteem voor premature baby’s, om stress en pijn te verminderen en de kwaliteit van zorg te verbeteren, wat ziekenhuisverblijven verkort en kosten verlaagt.